ATI RN
ATI Med-Surg Quiz N120 Cardio Gallader Questions
Extract:
Question 1 of 5
A nurse is caring for a client who is developing signs of hemorrhage after 5 days of continuous warfarin use. Which of the following labs should the nurse utilize to determine the medication's current therapeutic level?
Correct Answer: B
Rationale: Prothrombin time (PT) and international normalized ratio (INR) are used to monitor the therapeutic level of warfarin. INR is the preferred method as it standardizes the PT results across different laboratories.
Question 2 of 5
A nurse is providing discharge teaching for a client who has a new prescription for warfarin. Which of the following statements should the nurse include in the teaching?
Correct Answer: B
Rationale: Warfarin increases the risk of bleeding, so it is important for the client to avoid activities or clothing that may increase the risk of injury or bleeding, such as tight or restrictive clothing.
Question 3 of 5
A nurse is caring for a client who has sepsis and a prescription for vancomycin 1 g in 500 mL dextrose 5% (DW) over 4 hours by IV intermittent bolus. The nurse should set the IV pump to deliver how many mL/hr?
Correct Answer: 125
Rationale: The nurse should set the IV pump to deliver 125 mL/hr, calculated as follows: IV pump rate = 500 mL ÷ 4 hr = 125 mL/hr.
Question 4 of 5
A nurse is caring for a client who is developing signs of hemorrhage after 5 days of continuous warfarin use. Which of the following labs should the nurse utilize to determine the medication's current therapeutic level?
Correct Answer: B
Rationale: Prothrombin time (PT) and international normalized ratio (INR) are used to monitor the therapeutic level of warfarin. INR is the preferred method as it standardizes the PT results across different laboratories.
Question 5 of 5
A nurse is reviewing the medical history of a client who has a prescription for atenolol 40 mg daily. The nurse knows which of the following findings is a contraindication to the new medication?
Correct Answer: B
Rationale: Atenolol is a beta-blocker, and its use is contraindicated in clients with bronchial asthma or a history of severe bronchospastic disease due to the risk of exacerbating bronchospasm.